Product Description
| Cat Number | CV-020 |
|---|---|
| Category | Peptide |
| Pack Size | 10 mg |
| Description | Broad spectrum antiparasitic and antiviral |
| Purity | >98% by hplc, NMR conforms to standard |
| Biomarker Target | Other proteases,Antiparasitics |
| Sequence Three Letter Code | O-[N-(5-Nitrothiazol-2-yl)carbamoyl]phenyl acetate |
| Molecular Formula | C12H9N3O5S |
| Sl Sequence | O-[N-(5-Nitrothiazol-2-yl)carbamoyl]phenyl acetate |
| Solubility | Soluble in DMSO to 50mg/ml |
| Appearance | Off-white powder |
| Storage | Store desiccated, frozen and in the dark |
| References |
Sisson et al (2002) Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob. Agents Chemother. 46(7) 2116 PMID: 12069963Di Santo and Ehrisman (2013) Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose? Cancers 5(3) 1163 PMID: 24202339Liu et al (2020) Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases. ACS Cent. Sci. 6(3) 315 PMID: 32226821 Related areasAll small molecules >All antiviral agents >All antiparasitic agents > |
| Note | The product is for research use only |
Share Item: